Symmetric dimethylarginine (SDMA) is raised in women with polycystic ovary syndrome: A pilot study

References

• Abbasi F, Asagmi T, Cooke JP, Lamendola C, Mclaughlin T, Reaven GM et al. 2001. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. American Journal of Cardiology 88:1201–1203.
   PubMed Web of Science ®Google Scholar
• Boger RH. 2003. Association of asymmetric dimethylarginine and endothelial dysfunction. Chemistry and Laboratory Medicine 41:1467–1472.
   PubMed Web of Science ®Google Scholar
• Boger RH, Bode-Boger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP. 1998. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98:1842–1847.
   Google Scholar
• Bogle RG, MacAllister RJ, Whitley GS, Vallance P. 1995. Induction of NG-monomethyl-L-arginine uptake: a mechanism for differential inhibition of NO synthases? American Journal of Physiology 269:C750–C756.
   PubMedGoogle Scholar
• Christian RC, Dumesic DA, Behrenbeck T, Oberg AL, Sheedy PF, Fitzpatrick LA. 2003. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 88:2562–2568.
   PubMed Web of Science ®Google Scholar
• Closs EI, Basha FZ, Habermeier A, Forstermann U. 1997. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1:65–73.
   PubMed Web of Science ®Google Scholar
• Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO et al. 1992. Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertility and Sterility 57:505–513.
   PubMed Web of Science ®Google Scholar
• Dunaif A, Segal KR, Futterweit W, Dobrjansky A. 1989. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38:1165–1174.
   PubMed Web of Science ®Google Scholar
• Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. 2006. Endothelial dysfunction: a comprehensive appraisal. Cardiovascular Diabetology 5:4.
   PubMed Web of Science ®Google Scholar
• Franks S. 1995. Polycystic ovary syndrome. New England Journal of Medicine 333:853–861.
   PubMed Web of Science ®Google Scholar
• Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S et al. 2008. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. Journal of Clinical Endocrinology and Metabolism 93:82–90.
   PubMed Web of Science ®Google Scholar
• Kiechl S, Lee T, Santer P, Thompson G, Tsimikas S, Egger G et al. 2009. Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 205:261–265.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Zoccali C. 2008. Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease. Current Opinion in Nephrology and Hypertension 17:609–615.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska K, Mittermayer F, Wolzt M, Schernthaner S. 2007. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes. Diabetes Care 30:1834–1839.
   PubMed Web of Science ®Google Scholar
• Lakhani K, Hardiman P, Seifalian AM. 2004. Intima-media thickness of elastic and muscular arteries of young women with polycystic ovaries. Atherosclerosis 175:353–359.
   PubMed Web of Science ®Google Scholar
• Lakhani K, Leonard A, Seifalian AM, Hardiman P. 2005. Microvascular dysfunction in women with polycystic ovary syndrome. Human Reproduction 20:3219–3224.
   PubMed Web of Science ®Google Scholar
• Lakhani K, Seifalian AM, Hardiman P. 2002. Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106:81–85.
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al. 2007. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clinical Chemistry 53:766–772.
   PubMed Web of Science ®Google Scholar
• Nijveldt RJ, van Leeuwen PA, van Guldener C, Stehouwer CD, Rauwerda JA, Teerlink T. 2002. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrology Dialysis Transplantation 17:1999–2002.
   PubMed Web of Science ®Google Scholar
• Ozgurtas T, Oktenli C, Dede M, Tapan S, Kenar L, Sanisoglu SY et al. 2007. Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS). Atherosclerosis 200:336–344.
   Web of Science ®Google Scholar
• Paradisi G, Steinberg HO, Hempfling A, Cronin J, Hook G, Shepard MK et al. 2001. Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 103:1410–1415.
   PubMed Web of Science ®Google Scholar
• Perticone F, Sciacqua A, Maio R, Perticone M, Galianoleone G, Bruni R et al. 2010. Endothelial dysfunction, ADMA and insulin resistance in essential hypertension. International Journal of Cardiology 142:236–241.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25.
   Google Scholar
• Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, Kuller L. 1995. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 15:821–826.
   PubMed Web of Science ®Google Scholar
• Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE et al. 2000. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arteriosclerosis, Thrombosis, and Vascular Biology 20:2414–2421.
   PubMed Web of Science ®Google Scholar
• Teerlink T. 2007. HPLC analysis of ADMA and other methylated l-arginine analogs in biological fluids. Journal of Chromatography 851:21–29.
   Web of Science ®Google Scholar
• Valkonen V-P, Päivä H, Salonen JT, Lakka TA, Lehtimäki T, Laakso J et al. 2001. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127–2128.
   PubMed Web of Science ®Google Scholar